The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses.

The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses.
复制标题

抗癌 T 细胞免疫反应中 MHC 呈递的抗原加工中自噬和内/外泌体途径之间的串扰

DOI:
10.1186/s13045-017-0534-8
复制
发表时间:
2017-10-23
影响因子:
28.5
通讯作者:
Qian W
Qian W
中科院分区:
医学1区
文献类型:
--
作者:
You L;Mao L;Wei J;Jin S;Yang C;Liu H;Zhu L;Qian W

文献摘要

参考文献

被引文献

相似文献

T细胞识别以主要组织相容性复合体(MHC)分子多肽形式呈现给它们的蛋白水解产物中的抗原片段,这对于T细胞识别感染或转化的细胞至关重要。自噬是一种为溶酶体降解提供细胞质成分的过程,已被观察到为MHC向T细胞呈递提供细胞内和细胞外抗原的大量来源,这将影响肿瘤特异性免疫反应。同时,细胞外成分通过内/外泌体途径转运到细胞质中进行降解/分泌过程,从而参与多种生理和病理过程,包括免疫反应。自噬和内/外泌体通路以高度复杂的方式交织在一起,两者都密切参与MHC呈递的抗原加工;因此,我们认为它们可能在抗癌T细胞免疫反应中协调抗原加工和递呈。在本文中,我们讨论了自噬和内/外泌体途径之间的分子和功能串扰,以及它们在抗癌T细胞免疫应答中对MHC呈递抗原加工的贡献。
T cells recognize antigen fragments from proteolytic products that are presented to them in the form of peptides on major histocompatibility complex (MHC) molecules, which is crucial for the T cell to identify infected or transformed cells. Autophagy, a process that delivers cytoplasmic constituents for lysosomal degradation, has been observed to provide a substantial source of intra- and extracellular antigens for MHC presentation to T cells, which will impact the tumor-specific immune response. Meanwhile, extracellular components are transported to cytoplasm for the degradation/secretion process by the endo-/exosomal pathway and are thus involved in multiple physiological and pathological processes, including immune responses. Autophagy and endo-/exosomal pathways are intertwined in a highly intricate manner and both are closely involved in antigen processing for MHC presentation; thus, we propose that they may coordinate in antigen processing and presentation in anticancer T cell immune responses. In this article, we discuss the molecular and functional crosstalk between autophagy and endo-/exosomal pathways and their contributions to antigen processing for MHC presentation in anticancer T cell immune responses.
DOI: 10.1038/mt.2008.1
发表时间: 2008-04
期刊: Molecular therapy : the journal of the American Society of Gene Therapy
影响因子: --
作者:
Dai S;Wei D;Wu Z;Zhou X;Wei X;Huang H;Li G
通讯作者: Li G
DOI: 10.1007/s00109-006-0102-0
发表时间: 2006-12
期刊: Journal of molecular medicine (Berlin, Germany)
影响因子: --
作者:
Dai S;Zhou X;Wang B;Wang Q;Fu Y;Chen T;Wan T;Yu Y;Cao X
通讯作者: Cao X
DOI: 10.1016/s0264-410x(02)00384-5
发表时间: 2002-12-19
期刊: VACCINE
影响因子: 5.5
作者:
André, F;Scharz, NEC;Zitvogel, L
通讯作者: Zitvogel, L
DOI: 10.1182/blood-2011-09-376475
发表时间: 2012-06-28
期刊: BLOOD
影响因子: 20.3
作者:
Griffiths, Rebecca E.;Kupzig, Sabine;Anstee, David J.
通讯作者: Anstee, David J.
DOI: 10.1016/s0022-1759(00)00321-5
发表时间: 2001-01-01
影响因子: 2.2
作者:
Clayton, A;Court, J;Jasani, B
通讯作者: Jasani, B